Diabetes
News
FDA approves first-line combo therapy for type 2 diabetes
News
Severe foot pathology predicts death in diabetes
Key clinical point: Severe foot pathology was a better predictor of mortality than cardiovascular risk factors. Major finding: Patients with...
Conference Coverage
When 1 + 1 = 3: Rational drug combinations in type 2 diabetes
Conference Coverage
Liraglutide cut risk of microvascular renal complications by 22% in type 2 diabetes; no eye benefit
Key clinical point: Liraglutide protected kidney function but conferred no benefit on microvascular eye complications in patients with type 2...
Conference Coverage
Exenatide/dapagliflozin combo may be better in stubborn diabetes
The investigators note that this study “provides high-quality evidence that the combination of exenatide and dapagliflozin is more effective than...
News
Dulaglutide plus insulin glargine drops HbA1c in poorly controlled type 2
Key clinical point: Adding dulaglutide to insulin glargine and metformin significantly improved long-term blood glucose levels. Major finding: The...
News
Insulin-dependent pilots can fly safely with glucose monitoring protocol
Key clinical point: A protocol of regular blood glucose monitoring during flight is keeping British commercial pilots in the air. Major finding:...
News
Brain atrophy is already evident in patients with prediabetes
Key clinical point: People with prediabetes and type 2 diabetes have more white matter hyperintensities and lower white matter volume than do...
Conference Coverage
Both prepregnancy and gestational diabetes bode ill for babies
Key clinical point: Pregestational and gestational diabetes increase the risk of a several poor neonatal outcomes. Major finding: Pregestational...
News
Four-step screen IDs silent heart attack in type 2 diabetes
A four-component imaging/biomarker screen was highly accurate for identifying silent myocardial infarction among asymptomatic patients with type 2...